Cargando…

Development of Terahertz Imaging Markers for Pancreatic Ductal Adenocarcinoma using Maximum A Posteriori Probability (MAP) Estimation

[Image: see text] Pancreatic ductal adenocarcinoma (PDAC) is one of the significant reasons for cancer-related death in the United States due to a lack of timely prognosis and the poor efficacy of the standard treatment protocol. Immunotherapy-based neoadjuvant therapy, such as stereotactic body rad...

Descripción completa

Detalles Bibliográficos
Autores principales: Chakraborty, Debamitra, Mills, Bradley N., Cheng, Jing, Komissarov, Ivan, Gerber, Scott A., Sobolewski, Roman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034990/
https://www.ncbi.nlm.nih.gov/pubmed/36969433
http://dx.doi.org/10.1021/acsomega.2c07080
_version_ 1784911329122844672
author Chakraborty, Debamitra
Mills, Bradley N.
Cheng, Jing
Komissarov, Ivan
Gerber, Scott A.
Sobolewski, Roman
author_facet Chakraborty, Debamitra
Mills, Bradley N.
Cheng, Jing
Komissarov, Ivan
Gerber, Scott A.
Sobolewski, Roman
author_sort Chakraborty, Debamitra
collection PubMed
description [Image: see text] Pancreatic ductal adenocarcinoma (PDAC) is one of the significant reasons for cancer-related death in the United States due to a lack of timely prognosis and the poor efficacy of the standard treatment protocol. Immunotherapy-based neoadjuvant therapy, such as stereotactic body radiotherapy (SBRT), has shown promising results compared to conventional radiotherapy in strengthening the antitumor response in PDAC. To probe and quantify the antitumor response with SBRT, we propose to study the tumor microenvironment using terahertz time-domain spectroscopy (THz-TDS). Since the tumor’s complex microenvironment plays a key role in disease progression and treatment supervision, THz-TDS can be a revolutionary tool to help in treatment planning by probing the changes in the tissue microenvironment. This paper presents THz-TDS of paraffin-embedded PDAC samples utilizing a clinically relevant genetically engineered mouse model. This Article aims to develop and validate a novel time-domain approximation method based on maximum a posteriori probability (MAP) estimation to extract terahertz parameters, namely, the refractive index and the absorption coefficient, from THz-TDS. Unlike the standard frequency-domain (FD) analysis, the parameters extracted from MAP construct better-conserved tissue parameters estimates, since the FD optimization often incorporates errors due to numerical instabilities during phase unwrapping, especially when propagating in lossy media. The THz-range index of refraction extracted from MAP and absorption coefficient parameters report a statistically significant distinction between PDAC tissue regions and their healthy equivalents. The coefficient of variation of the refractive index extracted by MAP is one order of magnitude lower compared to the one extracted from FD analysis. The index of refraction and absorption coefficient extracted from the MAP are suggested as the best imaging markers to reconstruct THz images of biological tissues to reflect their physical properties accurately and reproducibly. The obtained THz scans were validated using standard histopathology.
format Online
Article
Text
id pubmed-10034990
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-100349902023-03-24 Development of Terahertz Imaging Markers for Pancreatic Ductal Adenocarcinoma using Maximum A Posteriori Probability (MAP) Estimation Chakraborty, Debamitra Mills, Bradley N. Cheng, Jing Komissarov, Ivan Gerber, Scott A. Sobolewski, Roman ACS Omega [Image: see text] Pancreatic ductal adenocarcinoma (PDAC) is one of the significant reasons for cancer-related death in the United States due to a lack of timely prognosis and the poor efficacy of the standard treatment protocol. Immunotherapy-based neoadjuvant therapy, such as stereotactic body radiotherapy (SBRT), has shown promising results compared to conventional radiotherapy in strengthening the antitumor response in PDAC. To probe and quantify the antitumor response with SBRT, we propose to study the tumor microenvironment using terahertz time-domain spectroscopy (THz-TDS). Since the tumor’s complex microenvironment plays a key role in disease progression and treatment supervision, THz-TDS can be a revolutionary tool to help in treatment planning by probing the changes in the tissue microenvironment. This paper presents THz-TDS of paraffin-embedded PDAC samples utilizing a clinically relevant genetically engineered mouse model. This Article aims to develop and validate a novel time-domain approximation method based on maximum a posteriori probability (MAP) estimation to extract terahertz parameters, namely, the refractive index and the absorption coefficient, from THz-TDS. Unlike the standard frequency-domain (FD) analysis, the parameters extracted from MAP construct better-conserved tissue parameters estimates, since the FD optimization often incorporates errors due to numerical instabilities during phase unwrapping, especially when propagating in lossy media. The THz-range index of refraction extracted from MAP and absorption coefficient parameters report a statistically significant distinction between PDAC tissue regions and their healthy equivalents. The coefficient of variation of the refractive index extracted by MAP is one order of magnitude lower compared to the one extracted from FD analysis. The index of refraction and absorption coefficient extracted from the MAP are suggested as the best imaging markers to reconstruct THz images of biological tissues to reflect their physical properties accurately and reproducibly. The obtained THz scans were validated using standard histopathology. American Chemical Society 2023-03-08 /pmc/articles/PMC10034990/ /pubmed/36969433 http://dx.doi.org/10.1021/acsomega.2c07080 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Chakraborty, Debamitra
Mills, Bradley N.
Cheng, Jing
Komissarov, Ivan
Gerber, Scott A.
Sobolewski, Roman
Development of Terahertz Imaging Markers for Pancreatic Ductal Adenocarcinoma using Maximum A Posteriori Probability (MAP) Estimation
title Development of Terahertz Imaging Markers for Pancreatic Ductal Adenocarcinoma using Maximum A Posteriori Probability (MAP) Estimation
title_full Development of Terahertz Imaging Markers for Pancreatic Ductal Adenocarcinoma using Maximum A Posteriori Probability (MAP) Estimation
title_fullStr Development of Terahertz Imaging Markers for Pancreatic Ductal Adenocarcinoma using Maximum A Posteriori Probability (MAP) Estimation
title_full_unstemmed Development of Terahertz Imaging Markers for Pancreatic Ductal Adenocarcinoma using Maximum A Posteriori Probability (MAP) Estimation
title_short Development of Terahertz Imaging Markers for Pancreatic Ductal Adenocarcinoma using Maximum A Posteriori Probability (MAP) Estimation
title_sort development of terahertz imaging markers for pancreatic ductal adenocarcinoma using maximum a posteriori probability (map) estimation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034990/
https://www.ncbi.nlm.nih.gov/pubmed/36969433
http://dx.doi.org/10.1021/acsomega.2c07080
work_keys_str_mv AT chakrabortydebamitra developmentofterahertzimagingmarkersforpancreaticductaladenocarcinomausingmaximumaposterioriprobabilitymapestimation
AT millsbradleyn developmentofterahertzimagingmarkersforpancreaticductaladenocarcinomausingmaximumaposterioriprobabilitymapestimation
AT chengjing developmentofterahertzimagingmarkersforpancreaticductaladenocarcinomausingmaximumaposterioriprobabilitymapestimation
AT komissarovivan developmentofterahertzimagingmarkersforpancreaticductaladenocarcinomausingmaximumaposterioriprobabilitymapestimation
AT gerberscotta developmentofterahertzimagingmarkersforpancreaticductaladenocarcinomausingmaximumaposterioriprobabilitymapestimation
AT sobolewskiroman developmentofterahertzimagingmarkersforpancreaticductaladenocarcinomausingmaximumaposterioriprobabilitymapestimation